Burn-Induced Cardiac Mitochondrial Dysfunction via Interruption of the PDE5A-cGMP-PKG Pathway

Jake J Wen1, Claire B Cummins1, Ravi S Radhakrishnan1

  • 1Division of Pediatric Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.

Insights

Severe burns cause heart dysfunction by damaging cardiac mitochondria and disrupting the PDE5A-cGMP-PKG pathway. Sildenafil treatment protected heart function by preserving mitochondrial integrity and energy status.

Area of Science:

  • Cardiovascular Science
  • Mitochondrial Biology
  • Burn Medicine

Background:

  • Burn-induced heart dysfunction is a significant cause of mortality.
  • The precise molecular mechanisms underlying this cardiac dysfunction remain unclear.
  • Investigating the role of mitochondrial function and specific signaling pathways is crucial.

Purpose of the Study:

  • To investigate the association between burn-induced heart dysfunction and cardiac mitochondrial dysfunction.
  • To determine the involvement of the phosphodiesterase type 5 A (PDE5A)-cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) pathway in burn injury.
  • To evaluate the therapeutic potential of sildenafil, a PDE5A inhibitor, in mitigating burn-induced cardiac damage.

Main Methods:

  • Utilized a rat model of severe scald burn (60% total body surface area).
  • Employed transmission electron microscopy (TEM), real-time quantitative polymerase chain reaction (qPCR), O2K-respirometry, and electron transport chain assays.
  • Assessed cardiac mitochondrial morphology, replication, gene expression, respiratory capacity, and enzyme activities.

Main Results:

  • Burn injury led to disfigured mitochondrial morphology, reduced mitochondrial number and size, and impaired mitochondrial replication.
  • Significant decreases in mitochondrial DNA (mtDNA)-encoded genes, State 3 oxygen consumption, and respiratory control ratios (RCRs) were observed.
  • Activities of mitochondrial complexes (except Complex II), ATP production, and manganese superoxide dismutase (MnSOD) were reduced post-burn.
  • Sildenafil treatment preserved mitochondrial structure, improved respiratory chain efficiency, maintained energy status, and restored ADP-conjugated respiration.

Conclusions:

  • Cardiac mitochondrial damage is a key contributor to burn-induced heart dysfunction.
  • The PDE5A-cGMP-PKG pathway plays a critical role in mediating these effects.
  • Sildenafil demonstrates a protective effect against burn-induced cardiac mitochondrial dysfunction and subsequent heart dysfunction.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
283
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
122
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K